These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 6744550

  • 21. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S.
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [Abstract] [Full Text] [Related]

  • 22. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A, Di Pede F, Delise P, Piccolo E.
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS, Uricchio F, Estes NA.
    Am J Cardiol; 1989 May 01; 63(15):1052-7. PubMed ID: 2705375
    [Abstract] [Full Text] [Related]

  • 24. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
    Morady F, Scheinman MM, Hess DS, Sung RJ, Shen E, Shapiro W.
    Am J Cardiol; 1983 Jan 01; 51(1):85-9. PubMed ID: 6849269
    [Abstract] [Full Text] [Related]

  • 25. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 26. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct 01; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 27. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
    Zhu J, Haines DE, Lerman BB, DiMarco JP.
    Circulation; 1987 Oct 01; 76(4):802-9. PubMed ID: 3652422
    [Abstract] [Full Text] [Related]

  • 28. Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms.
    Rinkenberger RL, Prystowsky EN, Jackman WM, Naccarelli GV, Heger JJ, Zipes DP.
    Am Heart J; 1982 Feb 01; 103(2):177-84. PubMed ID: 6798855
    [Abstract] [Full Text] [Related]

  • 29. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C, Brachmann J, Waldecker B, Rizos I, Senges J, Kübler W.
    Am Heart J; 1987 Aug 01; 114(2):279-83. PubMed ID: 3604883
    [Abstract] [Full Text] [Related]

  • 30. Value of serial electropharmacological testing in managing patients resuscitated from cardiac arrest.
    Raviele A, Di Pede F, Delise P, Piccolo E.
    Pacing Clin Electrophysiol; 1984 Sep 01; 7(5):850-60. PubMed ID: 6207498
    [Abstract] [Full Text] [Related]

  • 31. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP, Reid PR, Platia EV, Griffith LS.
    Am J Cardiol; 1985 Feb 01; 55(4):375-9. PubMed ID: 3969872
    [Abstract] [Full Text] [Related]

  • 32. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
    Strasberg B, Kusniec J, Zlotikamien B, Mager A, Sclarovsky S.
    Am J Cardiol; 1990 Sep 15; 66(7):673-8. PubMed ID: 2399883
    [Abstract] [Full Text] [Related]

  • 33. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ, Prystowsky EN, Zipes DP.
    Am Heart J; 1983 Oct 15; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [Abstract] [Full Text] [Related]

  • 34. Prognostic factors in nonsustained ventricular tachycardia.
    Buxton AE, Marchlinski FE, Waxman HL, Flores BT, Cassidy DM, Josephson ME.
    Am J Cardiol; 1984 May 01; 53(9):1275-9. PubMed ID: 6711427
    [Abstract] [Full Text] [Related]

  • 35. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM.
    Circulation; 1978 Dec 01; 58(6):986-97. PubMed ID: 709782
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy.
    Brembilla-Perrot B, Donetti J, de la Chaise AT, Sadoul N, Aliot E, Juillière Y.
    Am Heart J; 1991 Apr 01; 121(4 Pt 1):1124-31. PubMed ID: 2008835
    [Abstract] [Full Text] [Related]

  • 37. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS.
    Am J Cardiol; 1984 Aug 13; 54(4):37B-42B. PubMed ID: 6465045
    [Abstract] [Full Text] [Related]

  • 38. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction.
    Rodriguez LM, Smeets J, O'Hara GE, Geelen P, Brugada P, Wellens HJ.
    Am J Cardiol; 1992 Jun 01; 69(17):1403-6. PubMed ID: 1590227
    [Abstract] [Full Text] [Related]

  • 39. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure.
    Stevenson WG, Stevenson LW, Weiss J, Tillisch JH.
    Am Heart J; 1988 Dec 01; 116(6 Pt 1):1447-54. PubMed ID: 3195428
    [Abstract] [Full Text] [Related]

  • 40. Management of nonsustained ventricular tachycardia guided by electrophysiological testing.
    Kadish A, Schmaltz S, Calkins H, Morady F.
    Pacing Clin Electrophysiol; 1993 May 01; 16(5 Pt 1):1037-50. PubMed ID: 7685883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.